Explore more publications!
California Health Watch
Got News to Share?

California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

Press releases published on March 4, 2026

3billion Joins iHope Networks As First Laboratory In Asia
Mar. 4, 2026

3billion Joins iHope Networks As First Laboratory In Asia

Indeterminate EIN Presswire
OLOID Listed in Epic Toolbox, Expanding Passwordless Access for Clinical Workflows
Mar. 4, 2026

OLOID Listed in Epic Toolbox, Expanding Passwordless Access for Clinical Workflows

Indeterminate EIN Presswire
Outrun Cancer - The John Wayne Grit Series Pioneertown Half Marathon & 10K Benefiting John Wayne Cancer Foundation
Mar. 4, 2026

Outrun Cancer - The John Wayne Grit Series Pioneertown Half Marathon & 10K Benefiting John Wayne Cancer Foundation

Indeterminate EIN Presswire
From $6.7M to $12.1M: California Hospital Café Revenue Grows Over Three Years
Mar. 4, 2026

From $6.7M to $12.1M: California Hospital Café Revenue Grows Over Three Years

Indeterminate EIN Presswire
Author and Doctor of Energy Medicine Robin Lysne of The Center for the Soul Recently Featured on Close Up Radio
Mar. 4, 2026

Author and Doctor of Energy Medicine Robin Lysne of The Center for the Soul Recently Featured on Close Up Radio

Indeterminate EIN Presswire
13 Days Left: Up to $150,000 for First-Generation Southern California Buyers — Dream For All Registration Closes Mar 16
Mar. 4, 2026

13 Days Left: Up to $150,000 for First-Generation Southern California Buyers — Dream For All Registration Closes Mar 16

Indeterminate EIN Presswire
Fuel50 Research: Skills Adoption Surges, But Internal Hiring and Pay Transparency Lag
Mar. 4, 2026

Fuel50 Research: Skills Adoption Surges, But Internal Hiring and Pay Transparency Lag

Indeterminate EIN Presswire
Within Health Named to Forbes’ America’s Best Startup Employers 2026 for Second Consecutive Year
Mar. 4, 2026

Within Health Named to Forbes’ America’s Best Startup Employers 2026 for Second Consecutive Year

Indeterminate EIN Presswire
Dental Podcast Directory Surpasses 37,000 Episodes
Mar. 4, 2026

Dental Podcast Directory Surpasses 37,000 Episodes

Indeterminate EIN Presswire
Theolytics Awarded €8 million in Horizon Europe 2025 Grant Funding to Advance Phase 2 Study of THEO-260 in Ovarian Cancer
Mar. 4, 2026

Theolytics Awarded €8 million in Horizon Europe 2025 Grant Funding to Advance Phase 2 Study of THEO-260 in Ovarian Cancer

Indeterminate GlobeNewswire
Nxera Pharma Submits Marketing Authorization Application for Daridorexant in South Korea
Mar. 4, 2026

Nxera Pharma Submits Marketing Authorization Application for Daridorexant in South Korea

Indeterminate GlobeNewswire
HUTCHMED Initiates Global Trial of PI3K/PIKK-EGFR ATTC Candidate HMPL-A580 in Patients with Solid Tumors
Mar. 4, 2026

HUTCHMED Initiates Global Trial of PI3K/PIKK-EGFR ATTC Candidate HMPL-A580 in Patients with Solid Tumors

Indeterminate GlobeNewswire
Alvotech to Report Fourth Quarter and Full Year 2025 Financial Results
Mar. 4, 2026

Alvotech to Report Fourth Quarter and Full Year 2025 Financial Results

Indeterminate GlobeNewswire
Independent study presented at ECR highlights REGENERA™ bioresorbable scaffold potential for breast restoration after lumpectomy
Mar. 4, 2026

Independent study presented at ECR highlights REGENERA™ bioresorbable scaffold potential for breast restoration after lumpectomy

Indeterminate GlobeNewswire
BioVersys Announces Publication of BV100 Phase 1 Clinical Data in Journal of Antimicrobial Agents and Chemotherapy
Mar. 4, 2026

BioVersys Announces Publication of BV100 Phase 1 Clinical Data in Journal of Antimicrobial Agents and Chemotherapy

Indeterminate GlobeNewswire
DermaFix Nail Fungus Treatment Gel Claims Evaluated in 2026 Market Report Covering Tea Tree Oil Research, Penetration Technology Positioning, and Pricing Transparency
Mar. 4, 2026

DermaFix Nail Fungus Treatment Gel Claims Evaluated in 2026 Market Report Covering Tea Tree Oil Research, Penetration Technology Positioning, and Pricing Transparency

Indeterminate GlobeNewswire
MemoTril Cognitive Support Claims Evaluated: Latest 2026 Consumer Report Examines MemoTril Brain Supplement Ingredients, Memory Enhancement Marketing, and What Consumers Should Verify
Mar. 4, 2026

MemoTril Cognitive Support Claims Evaluated: Latest 2026 Consumer Report Examines MemoTril Brain Supplement Ingredients, Memory Enhancement Marketing, and What Consumers Should Verify

Indeterminate GlobeNewswire
Male Power XL "Black Elixir" Claims Evaluated: 2026 Report Examines Ingredient Research, Proprietary Blend Transparency, and What Men Should Verify Before Buying
Mar. 4, 2026

Male Power XL "Black Elixir" Claims Evaluated: 2026 Report Examines Ingredient Research, Proprietary Blend Transparency, and What Men Should Verify Before Buying

Indeterminate GlobeNewswire
AudiLeaf Ear Health Claims Evaluated: 2026 Report Examines Ingredients, Proprietary Blend Dosing, and What Consumers Should Verify Before Buying
Mar. 4, 2026

AudiLeaf Ear Health Claims Evaluated: 2026 Report Examines Ingredients, Proprietary Blend Dosing, and What Consumers Should Verify Before Buying

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions